391 related articles for article (PubMed ID: 18062719)
1. Treatment of lysosomal storage disorders : progress with enzyme replacement therapy.
Rohrbach M; Clarke JT
Drugs; 2007; 67(18):2697-716. PubMed ID: 18062719
[TBL] [Abstract][Full Text] [Related]
2. [Enzyme replacement therapy for lysosomal storage disorders].
Valayannopoulos V; Brassier A; Chabli A; Caillaud C; Lemoine M; Odent T; Arnoux JB; de Lonlay P
Arch Pediatr; 2011 Oct; 18(10):1119-23. PubMed ID: 21873040
[TBL] [Abstract][Full Text] [Related]
3. Treating lysosomal storage disorders: What have we learnt?
Lachmann RH
J Inherit Metab Dis; 2020 Jan; 43(1):125-132. PubMed ID: 31140601
[TBL] [Abstract][Full Text] [Related]
4. Enzyme replacement and enhancement therapies for lysosomal diseases.
Desnick RJ
J Inherit Metab Dis; 2004; 27(3):385-410. PubMed ID: 15190196
[TBL] [Abstract][Full Text] [Related]
5. The effectiveness and cost-effectiveness of enzyme and substrate replacement therapies: a longitudinal cohort study of people with lysosomal storage disorders.
Wyatt K; Henley W; Anderson L; Anderson R; Nikolaou V; Stein K; Klinger L; Hughes D; Waldek S; Lachmann R; Mehta A; Vellodi A; Logan S
Health Technol Assess; 2012; 16(39):1-543. PubMed ID: 23089251
[TBL] [Abstract][Full Text] [Related]
6. Enzyme replacement for lysosomal diseases.
Brady RO
Annu Rev Med; 2006; 57():283-96. PubMed ID: 16409150
[TBL] [Abstract][Full Text] [Related]
7. A charitable access program for patients with lysosomal storage disorders in underserved communities worldwide.
Mehta A; Ramaswami U; Muenzer J; Giugliani R; Ullrich K; Collin-Histed T; Panahloo Z; Wellhoefer H; Frader J
Orphanet J Rare Dis; 2021 Jan; 16(1):8. PubMed ID: 33407729
[TBL] [Abstract][Full Text] [Related]
8. Current enzyme replacement therapy for the treatment of lysosomal storage diseases.
Lim-Melia ER; Kronn DF
Pediatr Ann; 2009 Aug; 38(8):448-55. PubMed ID: 19725195
[No Abstract] [Full Text] [Related]
9. Pulmonary involvement in selected lysosomal storage diseases and the impact of enzyme replacement therapy: A state-of-the art review.
Jezela-Stanek A; Chorostowska-Wynimko J; Tylki-Szymańska A
Clin Respir J; 2020 May; 14(5):422-429. PubMed ID: 31912638
[TBL] [Abstract][Full Text] [Related]
10. Cardiac involvement in Lysosomal Storage Diseases.
Sestito S; Parisi F; Tallarico V; Tarsitano F; Roppa K; Pensabene L; Chimenz R; Ceravolo G; Calabrò MP; De Sarro R; Moricca MT; Bonapace G; Concolino D
J Biol Regul Homeost Agents; 2020; 34(4 Suppl. 2):107-119. SPECIAL ISSUE: FOCUS ON PEDIATRIC CARDIOLOGY. PubMed ID: 33000609
[TBL] [Abstract][Full Text] [Related]
11. Enzyme-replacement therapy for metabolic storage disorders.
Brady RO; Schiffmann R
Lancet Neurol; 2004 Dec; 3(12):752-6. PubMed ID: 15556808
[TBL] [Abstract][Full Text] [Related]
12. [Enzyme replacement therapy of lysosomal storage diseases].
Germain DP; Boucly C; Carlier RY; Caudron E; Charlier P; Colas F; Jabbour F; Martinez V; Mokhtari S; Orlikowski D; Pellegrini N; Perronne C; Prigent H; Rubinsztajn R; Benistan K
Rev Med Interne; 2010 Dec; 31 Suppl 2():S279-91. PubMed ID: 21211680
[TBL] [Abstract][Full Text] [Related]
13. A systematic review of the clinical effectiveness and cost-effectiveness of enzyme replacement therapies for Fabry's disease and mucopolysaccharidosis type 1.
Connock M; Juarez-Garcia A; Frew E; Mans A; Dretzke J; Fry-Smith A; Moore D
Health Technol Assess; 2006 Jun; 10(20):iii-iv, ix-113. PubMed ID: 16729919
[TBL] [Abstract][Full Text] [Related]
14. Enzyme replacement therapy for lysosomal diseases: lessons from 20 years of experience and remaining challenges.
Desnick RJ; Schuchman EH
Annu Rev Genomics Hum Genet; 2012; 13():307-35. PubMed ID: 22970722
[TBL] [Abstract][Full Text] [Related]
15. Enzyme replacement therapy for lysosomal storage diseases.
Ohashi T
Pediatr Endocrinol Rev; 2012 Oct; 10 Suppl 1():26-34. PubMed ID: 23330243
[TBL] [Abstract][Full Text] [Related]
16. [Enzyme replacement therapy for mucopolysaccharidoses I, II and VI: recommendations from a group of Brazilian F experts].
Giugliani R; Federhen A; Muñoz Rojas MV; Vieira TA; Artigalás O; Pinto LL; Azevedo AC; Acosta AX; Bomfim C; Lourenço CM; Kim CA; Horovitz D; Souza DB; Norato D; Marinho D; Palhares D; Santos ES; Ribeiro E; Valadares ER; Guarany F; De Lucca GR; Pimentel H; Souza IN; Corrêa Neto J; Fraga JC; Góes JE; Cabral JM; Simeonato J; Llerena JC; Jardim LB; Giuliani Lde R; Silva LC; Santos M; Moreira MA; Kerstenetzky M; Ribeiro M; Ruas N; Barrios P; Aranda P; Honjo R; Boy R; Costa R; Souza CF; Alcântara FF; Avilla SG; Fagondes S; Martins AM
Rev Assoc Med Bras (1992); 2010; 56(3):271-7. PubMed ID: 20676532
[TBL] [Abstract][Full Text] [Related]
17. New prospects for the treatment of lysosomal storage diseases.
Schiffmann R; Brady RO
Drugs; 2002; 62(5):733-42. PubMed ID: 11929328
[TBL] [Abstract][Full Text] [Related]
18. The role of antibodies in enzyme treatments and therapeutic strategies.
Bigger BW; Saif M; Linthorst GE
Best Pract Res Clin Endocrinol Metab; 2015 Mar; 29(2):183-94. PubMed ID: 25987172
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic Role of Pharmacological Chaperones in Lysosomal Storage Disorders: A Review of the Evidence and Informed Approach to Reclassification.
Keyzor I; Shohet S; Castelli J; Sitaraman S; Veleva-Rotse B; Weimer JM; Fox B; Willer T; Tuske S; Crathorne L; Belzar KJ
Biomolecules; 2023 Aug; 13(8):. PubMed ID: 37627292
[TBL] [Abstract][Full Text] [Related]
20. Neonatal screening for lysosomal storage disorders: feasibility and incidence from a nationwide study in Austria.
Mechtler TP; Stary S; Metz TF; De Jesús VR; Greber-Platzer S; Pollak A; Herkner KR; Streubel B; Kasper DC
Lancet; 2012 Jan; 379(9813):335-41. PubMed ID: 22133539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
